SCHEMBL513276

SCHEMBL513276

CCOC(=O)Oc1cc(=O)n(C)nc1C

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TNF P01375 1/20 0.40
CUL4A Q13619 2/20 0.39
BRD4 O60885 1/20 0.39
TYMS P04818 1/20 0.36
ALDH1A1 P00352 4/20 0.36
BAZ2B Q9UIF8 1/20 0.36
BAZ2A Q9UIF9 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KMT2A Q03164 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36
CLK1 P49759 1/20 0.36
UBE2N P61088 1/20 0.36
HSD17B10 Q99714 1/20 0.36
LMNA P02545 2/20 0.35
POLB P06746 1/20 0.35
PKM P14618 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL513376 0.90 KDM4E (0.35) BRD4BAZ2BLMNAPOLB
SCHEMBL18797088 0.74 BRD4 (0.47) BRD4SMN1; SMN2
SCHEMBL10745343 0.74 TNF (0.40) TNFALDH1A1SMN1; SMN2HPGDMAPK1
SCHEMBL3258080 0.71 ADORA3 (0.40) TNFCUL4ATYMSALDH1A1SMN1; SMN2
SCHEMBL513275 0.71 SMN1; SMN2 (0.38) TNFCUL4AALDH1A1RXFP1SMN1; SMN2
SCHEMBL10918321 0.70 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2KMT2AL3MBTL1HPGD
SCHEMBL9232485 0.69 KMT2A (0.44) TNFCUL4ATYMSALDH1A1BAZ2B
SCHEMBL5983543 0.69 ADORA2A (0.38) TNFCUL4ATYMSALDH1A1HSD17B10
SCHEMBL4664835 0.69 ADORA2A (0.44) TNFCUL4ATYMSALDH1A1KMT2A
SCHEMBL13611403 0.69 CYP1A2 (0.51) ALDH1A1BAZ2BBAZ2ASMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120028988-A1 USE OF PYRIDAZINONE COMPOUND FOR CONTROL OF HARMFUL ARTHROPOD PESTS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120028988-A1 USE OF PYRIDAZINONE COMPOUND FOR CONTROL OF HARMFUL ARTHROPOD PESTS PLPBP, PNPO, PIR TNF 4277/4885CUL4A 981/4885BRD4 3219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.